Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

6825 ARTÍCULOS , VIENDO DEL 4711 AL 4725

Memantine in patients with moderate to severe Alzheimer's disease: meta-analyses using realistic definitions of response

Wilkinson D, Wirth Y, Goebel C.

Dement Geriatr Cogn Disord. 2014;37(1-2):71-85. doi: 10.1159/000353801. Epub 2013 Oct 3.

Neuroinflammation and β amyloid deposition in Alzheimer's disease: in vivo quantification with molecular imaging

Hommet C, Mondon K, Camus V, Ribeiro MJ, Beaufils E, Arlicot N, Corcia P, Paccalin M, Minier F, Gosselin T, Page G, Guilloteau D, Chalon S.

Dement Geriatr Cogn Disord. 2014;37(1-2):1-18. doi: 10.1159/000354363. Epub 2013 Oct 1.

What should we do if we were wrong and Alzheimer was right?

Breitner JC.

Int Psychogeriatr. 2014 Jan;26(1):3-6. doi: 10.1017/S1041610213001749. Epub 2013 Oct 18.

The interest of amyloid PET imaging in the diagnosis of Alzheimer's disease

Vandenberghe R, Adamczuk K, Van Laere K.

Curr Opin Neurol. 2013 Dec;26(6):646-55. doi: 10.1097/WCO.0000000000000036.

[Informed consent to the insertion of a PEG tube in a 53-year-old male patient with highly advanced dementia]

Roden C.

Wien Med Wochenschr. 2014 May;164(9-10):167-71. doi: 10.1007/s10354-013-0245-x. Epub 2013 Oct 25.

Language-enriched exercise plus socialization for older adults with dementia: translation to rural communities

La Rue A, Felten K, Duschene K, MacFarlane D, Price S, Zimmerman S, Hafez S.

Semin Speech Lang. 2013 Aug;34(3):170-84. doi: 10.1055/s-0033-1358370. Epub 2013 Oct 28.

[New and future treatments for neurological disorders--knowledge essential to daily clinics and future prospects. Topics: 2. Dementia]

Moritoyo T.

Nihon Naika Gakkai Zasshi. 2013 Aug 10;102(8):1916-22. doi: 10.2169/naika.102.1916.

[Foreign body aspiration. An occasional finding in patients with dementia?]

Trevino-Peinado C, Paramo M, García del Barrio L, Riverol M.

Rev Clin Esp (Barc). 2014 Apr;214(3):e33. doi: 10.1016/j.rce.2013.09.007. Epub 2013 Oct 27.

Effect of methylphenidate on attention in apathetic AD patients in a randomized, placebo-controlled trial

Lanctôt KL, Chau SA, Herrmann N, Drye LT, Rosenberg PB, Scherer RW, Black SE, Vaidya V, Bachman DL, Mintzer JE.

Int Psychogeriatr. 2014 Feb;26(2):239-46. doi: 10.1017/S1041610213001762. Epub 2013 Oct 29.

PET radiotracers for imaging P-glycoprotein: the challenge for early diagnosis in AD

Leopoldo M, Contino M, Berardi F, Perrone R, Colabufo NA.

ChemMedChem. 2014 Jan;9(1):38-42. doi: 10.1002/cmdc.201300362. Epub 2013 Oct 31.

Effect of reinforcing kidney-essence, removing phlegm, and promoting mental therapy on treating Alzheimer's disease

Liu P, Kong M, Liu S, Chen G, Wang P.

J Tradit Chin Med. 2013 Aug;33(4):449-54. doi: 10.1016/s0254-6272(13)60147-8.

Contemplating Alzheimer's disease and the contribution of white matter hyperintensities

Brickman AM.

Curr Neurol Neurosci Rep. 2013 Dec;13(12):415. doi: 10.1007/s11910-013-0415-7.

Role for the neurexin-neuroligin complex in Alzheimer's disease

Sindi IA, Tannenberg RK, Dodd PR.

Neurobiol Aging. 2014 Apr;35(4):746-56. doi: 10.1016/j.neurobiolaging.2013.09.032. Epub 2013 Nov 6.

N-(3-(2-amino-6,6-difluoro-4,4a,5,6,7,7a-hexahydro-cyclopenta[e][1,3]oxazin-4-yl)-phenyl)-amides as BACE1 inhibitors: a patent evaluation of WO2013041499

Dessolin J.

Expert Opin Ther Pat. 2014 Feb;24(2):239-42. doi: 10.1517/13543776.2014.859246. Epub 2013 Nov 13.

Benefits of multimodal exercise intervention for postural control and frontal cognitive functions in individuals with Alzheimer's disease: a controlled trial

de Andrade LP, Gobbi LT, Coelho FG, Christofoletti G, Costa JL, Stella F.

J Am Geriatr Soc. 2013 Nov;61(11):1919-26. doi: 10.1111/jgs.12531. Epub 2013 Nov 5.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias